Mumbai : Maharashtra will not be allowed to sell Patanjali’s Coronil tablets without “proper credentials”, state Home Minister Anil Deshmukh said on Tuesday.
The statement came a day after the Indonesian Medical Association (IMA) lamented the “untruthfulness of WHO certification” for coronal tablets, which Patanjali claimed was evidence-based medicine for fighting Kovid-19.
The IMA also sought an explanation from Union Health Minister Harsh Vardhan, to whom the drug was introduced.
Deshmukh, who did not want to be named, said on Twitter that the two senior Union ministers’ support for the drug was “very impressive”.
Deshmukh said, “#IMA has questioned the alleged clinical trials of #Coronil and WHO. #Patanjali has denied the false claim of giving any certificate about the effectiveness of Ayurveda’s #Kovid19 treatment.
“… The sale of #Coronil will not be allowed without proper certification from appropriate health agencies like #WHO, #IMA and others,” the minister said.
Yoga guru Ramdev’s Patanjali Ayurveda said on February 19 that he had received a certificate from the Ministry of AYUSH as a CVV-19 treatment-supporting drug under the WHO certification scheme.
However, Acharya Balakrishna, Patanjali’s managing director, later said, “We want to avoid this conference by making it clear that our WHO GMP-compliant COPP certificate is Government of India, DCGI,” and “WHO does not approve or deny any drugs.”